Arbutus Biopharma Corp
ABUS
Market Cap$618.48M
Close$
$-0.36
111.1% downside
Current Fair Value
111.1% downsideOvervalued by 111.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $618.48 Million |
|---|---|
| Enterprise Value | $591.01 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.38 |
| Beta | 1.5 |
| Outstanding Shares | 189,963,492 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.78 |
|---|---|
| PEG | 455.87 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 87.66 |
| Enterprise Value to EBIT | -7.16 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Arbutus Biopharma Corp
CEO: William Collier